Immunotherapy of hepatocellular carcinoma

"Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death in the United States. Treatment options are limited. Viral hepatitis is one of the major risk factors for HCC, which represents a typical "inflammation-induced" cancer.

Saved in:
Bibliographic Details
Other Authors Greten, Tim F.
Format Electronic eBook
LanguageEnglish
Published Cham : Springer, 2017.
Subjects
Online AccessFull text
ISBN9783319649580
9783319649573
Physical Description1 online resource (x, 267 pages) : illustrations

Cover

Table of Contents:
  • Preface
  • Introduction
  • Vaccine approaches
  • Spontaneous Immune responses to ablative therapies
  • Antigen-specific T cell responses. Immune checkpoint inhibitors
  • NASH and HCC
  • Cytokine activated killer cells
  • Sorafenib combination therapy
  • Glypican 3
  • Suppressor cells
  • Cytokines in HCC pathogenesis and treatment
  • Index.